GPT and metabolic dysfunction-associated steatotic liver disease: The results not only provide new cues on the function of HIF3A methylation, but also provide evidence for identifying epigenetic factors of elivated ALT and may be useful for risk assessment and personalized medicine of liver diseases such as NAFLD.